Roche’s Polivy combination approved by European Commission for people with previously untreated diffuse large B-cell lymphoma May 25, 2022May 25, 2022 by / Share This.....LinkedinTwitterFacebookGoogleEmailRelated News: CHMP recommends EU approval of Roche’s Polivy…FDA accepts supplemental Biologics License…FDA Advisory Committee votes in favour of the…Roche presents new and updated data for Polivy in…Roche’s Polivy combination reduced the risk of…European Commission approves Roche’s first-in-class…
